In addition, the CD40 expression level has been shown to correlate with markers of antigen presentation and type-I T-cell responses, which are associated with a better OS in a pan-cancer study and therapeutic efficacy of ICI in several melanoma trials [55]. This evidence concerns the gene CD40 and melanoma.